🇺🇸 FDA
Patent

US 10449129

Encapsulates of salicylic acid and polysalicylic acid derivatives

granted A61KA61K31/765A61K8/11

Quick answer

US patent 10449129 (Encapsulates of salicylic acid and polysalicylic acid derivatives) held by Biocogent, LLC expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Biocogent, LLC
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/765, A61K8/11, A61K8/14, A61K8/368